1. M. Hollerhage, A. Matusch, P. Champy, A. Lombes, M. Ruberg, W. H. Oertel, and G. U. Hoglinger. Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologies. Exp Neurol, 2009. Note: Journal article. [WWW]



2. D. Alvarez-Fischer, C. Henze, C. Strenzke, J. Westrich, B. Ferger, G. U. Hoglinger, W. H. Oertel, and A. Hartmann. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice. Exp Neurol, 210(1):182-93, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adrenergic Agents/*toxicity, Animals, Behavior, Animal/drug effects, Brain Chemistry/drug effects, Corpus Striatum/*drug effects, Disease Models, Animal, Dose-Response Relationship, Drug, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Motor Activity/drug effects, Oxidopamine/*toxicity, *Parkinson Disease/etiology/genetics/physiopathology, Rotarod Performance Test/methods, Substantia Nigra/metabolism, Time Factors, Tyrosine 3-Monooxygenase/metabolism, alpha-Synuclein/*deficiency.



3. D. Alvarez-Fischer, G. Blessmann, C. Trosowski, M. Behe, T. Schurrat, A. Hartmann, T. M. Behr, W. H. Oertel, G. U. Hoglinger, and H. Hoffken. Quantitative [(123)I]FP-CIT pinhole SPECT imaging predicts striatal dopamine levels, but not number of nigral neurons in different mouse models of Parkinson's disease. Neuroimage, 38(1):5-12, 2007. Note: Journal ArticleUnited States. [WWW]



4. C. Depboylu, A. Matusch, F. Tribl, M. Zoriy, P. P. Michel, P. Riederer, M. Gerlach, S. Becker, W. H. Oertel, and G. U. Hoglinger. Glia protects neurons against extracellular human neuromelanin. Neurodegener Dis, 4(2-3):218-26, 2007. Note: Journal ArticleResearch Support, Non-U.S. Gov'tSwitzerland. [WWW]



5. M. Escobar-Khondiker, M. Hollerhage, M. P. Muriel, P. Champy, A. Bach, C. Depienne, G. Respondek, E. S. Yamada, A. Lannuzel, T. Yagi, E. C. Hirsch, W. H. Oertel, R. Jacob, P. P. Michel, M. Ruberg, and G. U. Hoglinger. Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons. J Neurosci, 27(29):7827-37, 2007. Note: Dk053244/dk/niddkNs048441/ns/nindsJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tUnited Statesthe official journal of the Society for Neuroscience. [WWW] Keyword(s): Adenosine Triphosphate/metabolism, Animals, Brain/cytology, Cell Death/drug effects, Cell Survival/drug effects, Cells, Cultured, Dose-Response Relationship, Drug, Embryo, Enzyme Inhibitors/*pharmacology, Female, Furans/*pharmacology, Lactones/*pharmacology, Microscopy, Immunoelectron/methods, Microtubule-Associated Proteins/metabolism, Neurons/*drug effects/metabolism/ultrastructure, Paclitaxel/pharmacology, Pregnancy, Rats, Rats, Wistar, Reactive Oxygen Species/metabolism, Tubulin Modulators/pharmacology, tau Proteins/*metabolism.



6. G. U. Hoglinger, J. J. Breunig, C. Depboylu, C. Rouaux, P. P. Michel, D. Alvarez-Fischer, A. L. Boutillier, J. Degregori, W. H. Oertel, P. Rakic, E. C. Hirsch, and S. Hunot. The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc Natl Acad Sci U S A, 104(9):3585-90, 2007. Note: R24 mh 68855/mh/nimhComparative StudyJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine/pharmacology, 1-Methyl-4-phenylpyridinium/pharmacology, Analysis of Variance, Animals, Apoptosis/*physiology, Chromatography, High Pressure Liquid, E2F1 Transcription Factor/genetics/*metabolism, Gene Expression Regulation/drug effects, Humans, Immunohistochemistry, In Situ Hybridization, Interneurons/drug effects/*metabolism, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Oligonucleotides, Antisense/genetics, Parkinson Disease/*physiopathology, Signal Transduction/drug effects, Substantia Nigra/*metabolism.



7. A. Lannuzel, G. U. Hoglinger, S. Verhaeghe, L. Gire, S. Belson, M. Escobar-Khondiker, P. Poullain, W. H. Oertel, E. C. Hirsch, B. Dubois, and M. Ruberg. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?. Brain, 130:816-827, 2007. Note: Part 3. [WWW]



8. N. Freundlieb, C. Francois, D. Tande, W. H. Oertel, E. C. Hirsch, and G. U. Hoglinger. Dopaminergic substantia nigra neurons project topographically organized to the subventricular zone and stimulate precursor cell proliferation in aged primates. J Neurosci, 26(8):2321-5, 2006. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited Statesthe official journal of the Society for Neuroscience. [WWW] Keyword(s): Aging/*metabolism/pathology, Animals, Cell Differentiation/physiology, Cell Proliferation, Cells, Cultured, Cercopithecus aethiops, Cerebral Ventricles/*cytology/metabolism, Dopamine/*metabolism, Macaca mulatta, Neural Pathways/cytology/metabolism, Neurons/*cytology/*metabolism, Stem Cells/*cytology/metabolism, Substantia Nigra/*cytology/metabolism, Tissue Distribution.



9. G. U. Hoglinger, W. H. Oertel, and E. C. Hirsch. The rotenone model of parkinsonism--the five years inspection. J Neural Transm Suppl, (70):269-72, 2006. Note: Journal ArticleReviewAustria. [WWW] Keyword(s): Animals, Disease Models, Animal, Dopamine/physiology, Humans, Movement/drug effects/physiology, Neurodegenerative Diseases/chemically induced/pathology, Neurons/pathology, Parkinson Disease, Secondary/*chemically induced/pathology/physiopathology, *Rotenone, Substantia Nigra/pathology, *Uncoupling Agents, tau Proteins/metabolism.



10. L. Lu, F. Neff, D. A. Fischer, C. Henze, E. C. Hirsch, W. H. Oertel, J. Schlegel, and A. Hartmann. Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects. Neurobiol Dis, 23(2):409-21, 2006. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Aged, Cadaver, DNA Primers, Dopamine/*analysis, Gene Expression Profiling, Humans, Mesencephalon/*pathology, Middle Aged, Nerve Degeneration, Nerve Tissue Proteins/genetics, Neurons/*pathology, Parkinson Disease/genetics/*pathology, Polymerase Chain Reaction, RNA/genetics/isolation & purification, Reference Values.



11. G. U. Hoglinger, A. Lannuzel, M. E. Khondiker, P. P. Michel, C. Duyckaerts, J. Feger, P. Champy, A. Prigent, F. Medja, A. Lombes, W. H. Oertel, M. Ruberg, and E. C. Hirsch. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J Neurochem, 95(4):930-9, 2005. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Amyloid beta-Protein/metabolism, Analysis of Variance, Animals, Antineoplastic Combined Chemotherapy Protocols/metabolism, Behavior, Animal, Body Weight/drug effects, Caspase 3, Caspases/metabolism, Cell Death/drug effects, Cerebral Cortex/*drug effects/pathology/physiopathology, Cytarabine/metabolism, Diagnostic Imaging/methods, Dopamine and cAMP-Regulated Phosphoprotein 32/metabolism, Doxorubicin/metabolism, Dystonia/etiology/physiopathology, Electron Transport Complex III/metabolism, Enzyme Activation/drug effects, Glial Fibrillary Acidic Protein/metabolism, Immunohistochemistry/methods, Locomotion/drug effects, Male, Microscopy, Electron, Transmission/methods, Mitochondria/drug effects/ultrastructure, Neurons/drug effects/physiology, Phosphopyruvate Hydratase/metabolism, Phosphorylation, Posture, Psychomotor Performance/drug effects, Rats, Rats, Inbred Lew, Rotenone/*adverse effects, Tauopathies/*chemically induced/pathology/physiopathology, Thiazoles/diagnostic use, Time Factors, Tyrosine/analogs & derivatives/metabolism, Tyrosine 3-Monooxygenase/metabolism, Ubiquitin/metabolism, Uncoupling Agents/*adverse effects, alpha-Synuclein/metabolism, tau Proteins/metabolism.



12. G. U. Hoglinger, P. Rizk, M. P. Muriel, C. Duyckaerts, W. H. Oertel, I. Caille, and E. C. Hirsch. Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci, 7(7):726-35, 2004. Note: Comparative StudyJournal ArticleResearch Support, U.S. Gov't, P.H.S.United States. [WWW] Keyword(s): Aged, Analysis of Variance, Animals, Antiparkinson Agents/therapeutic use, Bromodeoxyuridine/metabolism, Case-Control Studies, Cell Count/methods, Cell Death/physiology, Cell Division/drug effects, Cells, Cultured, Dopamine/*deficiency/physiology, Dopamine Antagonists/pharmacology, Dopamine Plasma Membrane Transport Proteins, Drug Interactions, Ependyma/ultrastructure, Female, Glial Fibrillary Acidic Protein/metabolism, Glycoproteins/metabolism, Humans, Immunohistochemistry/methods, In Situ Nick-End Labeling/methods, Indoles/therapeutic use, Intermediate Filament Proteins/metabolism, Levodopa/therapeutic use, Male, Membrane Glycoproteins/metabolism, Membrane Transport Proteins/metabolism, Mice, Mice, Inbred C57BL, Microscopy, Confocal/methods, Microscopy, Immunoelectron/methods, Microspheres, Middle Aged, Nerve Tissue Proteins/metabolism, Neural Cell Adhesion Molecule L1/metabolism, Neurons/metabolism/*pathology/ultrastructure, Olfactory Bulb/cytology/metabolism, Oxidopamine/toxicity, Parkinson Disease/drug therapy/*metabolism/*pathology, Parkinsonian Disorders/metabolism/pathology, Postmortem Changes, Rats, Rats, Sprague-Dawley, Receptor, Epidermal Growth Factor.



13. G. U. Hoglinger, J. Feger, A. Prigent, P. P. Michel, K. Parain, P. Champy, M. Ruberg, W. H. Oertel, and E. C. Hirsch. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem, 84(3):491-502, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Animals, Behavior, Animal/drug effects, Cell Count, Choline O-Acetyltransferase/biosynthesis, Chronic Disease, Corpus Striatum/drug effects/pathology, Disease Models, Animal, Dopamine and cAMP-Regulated Phosphoprotein 32, Drug Administration Schedule, Electron Transport Complex I, Enzyme Inhibitors/administration & dosage/*toxicity, Inclusion Bodies/pathology, Infusions, Intravenous, Locus Coeruleus/drug effects/pathology, Male, Mesencephalon/drug effects/pathology, Motor Activity/drug effects, Movement Disorders/complications/etiology/*pathology, NADH, NADPH Oxidoreductases/*antagonists & inhibitors, *Nerve Tissue Proteins, Neurodegenerative Diseases/chemically induced/complications/*pathology, Neuroglia/pathology, Neurons/drug effects/metabolism/pathology, Pesticides/toxicity, Phosphoproteins/biosynthesis, Rats, Rats, Inbred Lew, Rotenone/administration & dosage/*toxicity, Serotonin/biosynthesis, Substantia Nigra/drug effects/pathology, Time, Tyrosine 3-Monooxygenase/biosynthesis.



14. D. Sibbing, F. Asmus, I. R. Konig, S. Tezenas du Montcel, M. Vidailhet, S. Sangla, W. H. Oertel, A. Brice, A. Ziegler, T. Gasser, and O. Bandmann. Candidate gene studies in focal dystonia. Neurology, 61(8):1097-101, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase/*genetics, Cystathionine beta-Synthase/genetics, Dystonic Disorders/*genetics, Female, France, Gene Frequency, Genetic Predisposition to Disease, Genotype, Germany, HLA-DR Antigens/*genetics, Haplotypes, Humans, Male, Methylenetetrahydrofolate Reductase (NADPH2)/genetics, Molecular Chaperones/*genetics, Polymerase Chain Reaction, *Polymorphism, Genetic, Receptors, Dopamine D1/*genetics, Receptors, Dopamine D5.

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.

This document was translated from BibT_EX by bibtex2html